Comparison of Craniosacral Therapy vs Pelvic Floor Physical Therapy
A Comparison of Craniosacral Therapy vs Pelvic Floor Physical Therapy for the Treatment of Lower Urinary Tract Dysfunction in People With Multiple Sclerosis: A Pilot Study
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Pelvic Floor Physical Therapy
- Craniosacral Therapy
What it measured
Main measures
PFDI-20
Change from baseline PFDI-20 after six weeks of intervention
PFIQ-7
Change from baseline PFIQ-7 after six weeks of intervention
Bladder, bowel and sexual function
Other measures (9)
MSQOL-54
Change from baseline MSQOL-54 after six weeks of intervention
Quality of life (reported by participants)Post void residual volume
Change from baseline PVR after six weeks of intervention
Bladder, bowel and sexual functionResting SEMG
Change from baseline Resting SEMG after six weeks of intervention
Systolic BP
Change from baseline Systolic BP after six weeks of intervention
Systolic BP
Change from pre-intervention to post-intervention at each of six intervention sessions
Diastolic BP
Change from baseline Diastolic BP after six weeks of intervention
Diastolic BP
Change from pre-intervention to post-intervention at each of six intervention sessions
Pulse
Change from pre-intervention to post-intervention at each of six intervention sessions
Pulse
Change from baseline Pulse after six weeks of intervention
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Diagnosis of Multiple Sclerosis * Currently have the following symptoms for at least three (3) months or longer: frequent urination, increased urge to urinate, nighttime urination, loss/leakage of urine with or without activity, and/or problems emptying your bladder.
Exclusion criteria
* Unable or unwilling to give consent to be treated * Unable or unwilling to cover your portion of physical therapy treatment (i.e. co-pays and/or deductibles) * Cannot speak or read English * Have NOT had any urinary symptoms for at least three (3) months * Do not have Multiple Sclerosis; or have NOT been diagnosed with Multiple Sclerosis * Take medication to treat your urinary symptoms; or have taken medication in the past three (3) months to treat your urinary symptoms * Use an indwelling catheter (i.e. tube inserted into your bladder for continuous urine drainage); or you require intermittent catheterization * Currently are experiencing any of the following: shooting or radiating pain in your back or abdomen; pain that is not relieved with body position and/or medication; nausea; decreased appetite; pain with bowel movements or urination; and/or any symptom that is new and/or of unexplained onset (i.e. you do not know why it started or when it started) * Currently have cancer/tumors (i.e. tumors in the spine, brain, pelvis, etc.) and/or aneurysms (i.e. abdominal aortic aneurysm) * Received Botox injections in the past three (3) months * Received Pelvic Floor Physical Therapy and/or Craniosacral Therapy in the past three (3) months
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this study is to determine the efficacy of CST for the treatment of LUTS in patients with MS and evaluate the acute effects compared to PFPT. A. Objectives To examine the effect of CST as compared to PFPT on QOL, SEMG resting biofeedback readings, and PVR ultrasonography measures in patients with MS and LUTS. B. Hypotheses / Research Question(s) It is hypothesized that patients who receive CST will demonstrate improved QOL, bladder control and ability to empty bladder as compared to those who receive PFPT.
Loading reviews and guidelines…
History
Started
Apr 2017
Main results due
Apr 2018
Finished
Apr 2018